Dr. Yasser Riazalhosseini received a BSc degree in Microbiology from University of Isfahan in 2002, a MSc degree in Molecular and Cellular Biology from Khatam Institute of Higher Education in 2005, and the PhD in Molecular Biology from Heidelberg University in 2010.
After undertaking post-doctoral studies on Cancer Genomics at the Deutsches Krebsforschungszentrum (DKFZ; German Cancer Research Centre), Dr. Riazalhosseini joined the Department of Human Genetics at McGill as an Assistant Professor, and was appointed Group Head of the Cancer Genomics program at the McGill University and Genome Québec Innovation Centre (the McGill Genome Centre). His principal activity has been to initiate and lead a multidisciplinary, applied research program on cancer genomics, with a primary focus on renal cell carcinoma.
Dr. Riazalhossieni’s research is focused on understanding the genomic causes of solid cancers with the goals of obtaining better preventions and treatments. His research program uses systems biology approaches that combine genomics datasets involving sequences from hundreds of cancers coupled with detailed clinical data, and functional studies. Contributing to his research goals, Dr. Riazalhosseini has a major role in the Cancer Genomics of the Kidney (CAGEKID) consortium, part of International Cancer Genome Consortium (ICGC), where he has assumed joint responsibility for the data analysis and leads the down-steam validation of results.